Accelerated epigenetic aging involves Polycomb group proteins in Huntington’s diseaseBaptiste Brulé, Rafael Alcalá-Vida, Noémie Penaud et al.
Cas9 nickase-mediated contraction of CAG/CTG repeats at multiple disease lociAlvaro Murillo Bartolome, Alpaugh Melanie, Larin Meghan et al.
CD200-based cell sorting generates homogeneous subpopulations of transplantable striatal neuroblastsCinta Gomis, F. J. Molina-Ruiz, P. Sanders et al.
Clinical grade production of large-scale neural progenitor cells (NPC) for Huntington’s disease treatmentJosep M. Canals, Marc Estarellas, Georgina Bombau et al.
Connecting metabolic and epigenetic dysregulations in Huntington's diseaseNoémie Penaud, Baptiste Brulé, Hassan Hijazi et al.
Development of a new cell model of Huntington's disease to evaluate the effectiveness of potential drugs at preclinical stagesNina Kraskovskaya, Polina Parfionova, Natalia Mikhailova
Evolution of the psychiatric phenotype in the early stages of a Huntington's disease preclinical modelBaptiste Dayre, Katleen Pinchaud, Peter Vanhoutte, Sandrine Betuing
Functional impairments of striatal neurons in Huntington’s disease: Fast-spiking interneurons and their key role during the early stages of the pathologyArianna Trucco, Paolo Spaiardi, Antonio Nicolas Castagno et al.
Indirect pathway lineage-specific alterations during early development in Huntington’s diseaseCris Vila Torondel, Anna Esteve-Codina, Francisco Londoño et al.
K-Cl cotransporter KCC2 function is impaired in D2 receptor-expressing medium spiny neurons in a mouse model of Huntington's diseaseMelissa Serranilla, Jessica C. Pressey, Melanie A. Woodin
Light-dependent cAMP modulation in astrocytes triggers synaptic potentiation, hemodynamic responses, and behavioural changes in mice: Role in Huntington’s diseaseLaia Sitjà Roqueta, Neville M. Ngum, Evgenii Zherebtsov et al.
Meningeal immune cell alterations in Huntington’s diseaseAlina Blusch, Katharina Lemhoefer, Melissa Sgodzai et al.
Are mitochondria a missing link between arginase 2 loss and Huntington’s disease pathogenesis?Martyna Podgajna, Magdalena Gewartowska, Aleksandra Kaczynska et al.
Mutant huntingtin disrupts global DNA methylation in human iPSC-derived cerebral organoidsElad Dvir, Moria Maman, Xue Sun et al.
Neuroinflammatory pathways in the human midcingulate cortex in Huntington’s diseaseMackenzie Ferguson, Thulani H Palpagama, Clinton Turner et al.
Retinal dysfunction in Huntington’s disease mouse models is characterized by an early photoreceptor degeneration and a late neuroinflammationJorge Navarro Calvo, Paula Martín-Climent, Fátima Cano-Cano et al.
Sigma 2 receptor/TMEM97 as a potential therapeutic target for neurodegenerative disordersJing Jin, Zhengyuan Pan, Ainsley McCollum et al.
Superior colliculus as a key player in Huntington’s disease sensorimotor coordination deficits: From circuits to behaviourMelike Küçükerden, Sara Conde-Berriozabal, Laia Sitjà-Roqueta et al.
TAF1 splicing variants and prolyl hydroxylase inhibitors therapy in a mouse model of Huntington’s diseaseClaudia Rodríguez-López, Ivó H Hernández, Marcos Casado Barbero, Jose J Lucas
Targeting the AMPK pathway as a treatment strategy for Huntington’s diseaseBalázs Kis, Varga Ágnes, Hühn Daniela et al.
Unraveling glutamatergic dysregulation in RARβ null mice striatal synapses and its implications in neurological disordersHanna Semaan, Jean-Marc Strub, Christine Schaeffer-Reiss, Wojciech Krezel